Alkene compounds as farnesoid x receptor modulators
The present invention provides compounds of Formula (I): Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds modulate the activity of famesoid X receptor (FXR), for example, as agonists. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
Bristol-Myers Squibb Company
A C C C C C C A C
A61K C07D C07D C07D C07D C07D C07D A61K C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Matthias Joseph E. Jianxin Ying Chunjian Wei
Broekema Carpenter Feng Wang Liu Wang